The key question is how to determine the right level of fees so that they cover the actual costs of services provided to companies but do not hamper innovation and the introduction of new medicinal products and thus the competitiveness of the European pharmaceutical industry.
The key question is how to determine the right level of fees so that they cover the actual costs of services provided to companies but do not hamper innovation and the introduction of new medicinal products and thus the competitiveness of the European pharmaceutical industry.